June 19, 2021

Dr. Martin Reich Receives the David Marsden Award 2021

Our congratulations to Dr. Martin Reich, from Julius Maximilian’s University, department of Neurology in Würzburg, Germany and the David Marsden Award 2021 for his paper: Probalistic mapping of the antidystonic effect of pallidal neurostimulation: a multi-centre imaging study. Today Dr. Reich was presented with the award by Dystonia Europe President Adam Kalinowski at the Basal…

Show this Post ›
May 30, 2021

DMRF Launches First Scientific Journal Dedicated to Dystonia

The Dystonia Medical Research Foundation (DMRF) has partnered with Frontiers to launch Dystonia, a Gold Open Access journal. The journal will bring visibility to the growing dystonia field and highlight advancements in science and clinical practice. “The field is ready for a journal focused solely on dystonia,” said Co-Editor-in-Chief Aasef Shaikh, MD, PhD, Penni and Stephen Weinberg…

Show this Post ›
May 13, 2021

New Consensus Guidelines for Botulinum Toxin Therapy of Dystonia and Spasticity

Professor Dirk Dressler Botulinum toxin (BT) therapy is based on applying appropriate doses of BT into an appropriate selection of muscles. Both, the list of target muscles together with their BT doses, constitute the dosing scheme. Developing the dosing scheme for each patient individually requires considerable experience and makes BT therapy what some people might call…

Show this Post ›
March 22, 2021

Medtronic Recieves CE Mark Approval for SenSightTM Directinoal Lead System for DBS Therapy

Press Release from Medtronic March 22, 2021 This First-of-its-Kind Directional Lead Combines the Benefits of Directionality with the Power of Sensing DUBLIN, March 22, 2021 /PRNewswire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the CE (Conformité Européenne) Mark for the SenSight™ directional lead system for Deep Brain Stimulation (DBS) therapy…

Show this Post ›